These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36983671)

  • 1. Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers.
    Saiz-Rodríguez M; Ochoa D; Zubiaur P; Navares-Gómez M; Román M; Camargo-Mamani P; Luquero-Bueno S; Villapalos-García G; Alcaraz R; Mejía-Abril G; Santos-Mazo E; Abad-Santos F
    J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of
    Chen P; Cao Y; Chen S; Liu Z; Chen S; Guo Y
    Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus.
    Pérez-Gómez N; Fernández-Ortega MD; Elizari-Roncal M; Santos-Mazo E; la Maza-Pereg L; Calvo S; Alcaraz R; Sanz-Solas A; Vinuesa R; Saiz-Rodríguez M
    Pharmacogenomics; 2023 Aug; 24(12):651-663. PubMed ID: 37610884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the genetic variants of organic cation transporters 1 and 3 on the pharmacokinetics of metformin in Jordanians.
    Hakooz N; Jarrar YB; Zihlif M; Imraish A; Hamed S; Arafat T
    Drug Metab Pers Ther; 2017 Sep; 32(3):157-162. PubMed ID: 28862982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran.
    Zubiaur P; Saiz-Rodríguez M; Ochoa D; Navares-Gómez M; Mejía G; Román M; Koller D; Soria-Chacartegui P; Almenara S; Abad-Santos F
    Adv Ther; 2020 Aug; 37(8):3537-3550. PubMed ID: 32564268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels.
    Al-Eitan LN; Almomani BA; Nassar AM; Elsaqa BZ; Saadeh NA
    J Pers Med; 2019 Mar; 9(1):. PubMed ID: 30934600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response.
    Ningrum VDA; Sadewa AH; Ikawati Z; Yuliwulandari R; Ikhsan MR; Fajriyah R
    PLoS One; 2022; 17(7):e0271410. PubMed ID: 35905099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Glycemic Control Associated With Polymorphisms in the SLC22A1 (OCT1) Gene in a Mexican Population With Type 2 Diabetes Mellitus Treated With Metformin: A Cohort Study.
    Reséndiz-Abarca CA; Flores-Alfaro E; Suárez-Sánchez F; Cruz M; Valladares-Salgado A; Del Carmen Alarcón-Romero L; Vázquez-Moreno MA; Wacher-Rodarte NA; Gómez-Zamudio JH
    J Clin Pharmacol; 2019 Oct; 59(10):1384-1390. PubMed ID: 31012983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of pharmacogenetic polymorphisms and demographic variables on metformin pharmacokinetics in an admixed Brazilian cohort.
    Santoro AB; Botton MR; Struchiner CJ; Suarez-Kurtz G
    Br J Clin Pharmacol; 2018 May; 84(5):987-996. PubMed ID: 29352482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of the SLC47A1 and SLC47A2 gene polymorphisms on the glycemic response to metformin in type 2 diabetes mellitus patients.
    Raj GM; Mathaiyan J; Wyawahare M; Priyadarshini R
    Drug Metab Pers Ther; 2018 Dec; 33(4):175-185. PubMed ID: 30433870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane Transporters and Carriers in Human Seminal Vesicles.
    Malinowski D; Grzegółkowski P; Piotrowska K; Słojewski M; Droździk M
    J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics.
    Zhou Q; Ruan ZR; Yuan H; Xu DH; Zeng S
    Pharmazie; 2013 Feb; 68(2):129-34. PubMed ID: 23469685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of
    Ortega-Ayala A; De Andrés F; Llerena A; Bartolo-Montiel CM; Molina-Guarneros JA
    Biomed Rep; 2024 Aug; 21(2):117. PubMed ID: 38938740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients.
    Xiao D; Guo Y; Li X; Yin JY; Zheng W; Qiu XW; Xiao L; Liu RR; Wang SY; Gong WJ; Zhou HH; Liu ZQ
    Int J Endocrinol; 2016; 2016():4350712. PubMed ID: 26977146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influences of organic cation transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects.
    Yoon H; Cho HY; Yoo HD; Kim SM; Lee YB
    AAPS J; 2013 Apr; 15(2):571-80. PubMed ID: 23417334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transporters Involved in Metformin Pharmacokinetics and Treatment Response.
    Liang X; Giacomini KM
    J Pharm Sci; 2017 Sep; 106(9):2245-2250. PubMed ID: 28495567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes medication associates with DNA methylation of metformin transporter genes in the human liver.
    García-Calzón S; Perfilyev A; Männistö V; de Mello VD; Nilsson E; Pihlajamäki J; Ling C
    Clin Epigenetics; 2017; 9():102. PubMed ID: 28947922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of organic cation transporter 2 improves glucose-lowering effect of metformin via influencing its pharmacokinetics in Chinese type 2 diabetic patients.
    Hou W; Zhang D; Lu W; Zheng T; Wan L; Li Q; Bao Y; Liu F; Jia W
    Mol Diagn Ther; 2015 Feb; 19(1):25-33. PubMed ID: 25573751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes.
    Tkáč I; Klimčáková L; Javorský M; Fabianová M; Schroner Z; Hermanová H; Babjaková E; Tkáčová R
    Diabetes Obes Metab; 2013 Feb; 15(2):189-91. PubMed ID: 22882994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of gefitinib pharmacokinetics in healthy Chinese male subjects: A pharmacogenomic study of cytochrome p450 enzymes and transporters.
    Wan Z; Guo L; Li P; Zhao Z; Xu B; Ren L; Yan Y; Liu H; Zhang Y; Liu L
    J Clin Pharm Ther; 2020 Oct; 45(5):1159-1167. PubMed ID: 32562509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.